SARS-CoV E2 Glycoprotein Antikörper
-
- Target Alle SARS-CoV E2 Glycoprotein (SARS-CoV E2) Produkte
- SARS-CoV E2 Glycoprotein (SARS-CoV E2) (SARS-Coronavirus E2 Glycoprotein (SARS-CoV E2))
- Reaktivität
- SARS Coronavirus (SARS-CoV)
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SARS-CoV E2 Glycoprotein Antikörper ist unkonjugiert
- Applikation
- ELISA, Western Blotting (WB)
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of SARS-E2 glycoprotein precursor expressed in E. coli.
- Klon
- 4A6C9
- Isotyp
- IgG1
-
anti-SARS-Coronavirus E2 Glycoprotein (SARS-CoV E2) antibody
SARS-CoV E2 Reaktivität: Human ELISA, WB Wirt: Maus Monoclonal 4A6C9 unconjugated
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Subclonal supernatant.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
- Target
- SARS-CoV E2 Glycoprotein (SARS-CoV E2) (SARS-Coronavirus E2 Glycoprotein (SARS-CoV E2))
- Andere Bezeichnung
- SARS-E2 (SARS-CoV E2 Produkte)
- Substanzklasse
- Viral Protein
- Hintergrund
-
Description: SARS (severe acute respiratory syndrome) is caused by a human coronavirus. Human coronaviruses are the major cause of upper respiratory tract illness, such as the common cold, in humans. Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb). The complete sequence of the SARS virus release the coronavirus contains 25 open reading frames. SARS-E2 glycoprotein precursor is a 139- kDa glycoprotein. It contains a superantigen between residues 690 through 1050 which has relationship to T-cell Receptor alpha-beta V chain protein.
Aliases: N/A
-
